维普期刊资源整合服务平台（V6.5）

87篇 您的检索式：期刊名="Sem In Oncol"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	Aromatase inhibitors mechanism of action and role in the treatment of breast cancer显示文摘	Miller W R	2003	Sem in Oncol2003，30，4：	1
2	Oxaliplatin-related side effects : characteris- tics and management显示文摘	Cassidy J Misset J L	2002	Sem in Oncol2002，29，：	1
3	The mechanisms of action of Rituximab in the elimination of tumor cells 显示文摘	Iohnson P Glennie M	2003	Sem in Oncol2003，30，12：	1
4	Breast cancer and pregnancy显示文摘	Foster RS Jr	2000	Sem in Oncol2000，27，4：	1
5	Pathogenesis and medi- cal treatment of secondary hype rparathyroidism显示文摘	FUKAGAWA M KUROKAWA K	1997	Sem in Surgical Oncol1997，13，：	1
6	Targeting the HER-kinase axis in cancer显示文摘	Gross ME Shazer RL Agus DB	2004	Sem in Oncol2004，31，13：	1
7	P53 gene therapy in vivo of hepatocellular and liver metastatic colorectal cancer显示文摘	Bookstein R Demers W Gregory R	1996	Sem in oncol1996，23，：	1
8	A historical perspective on oxalipatin:rethinking the role of platinum compounds and learning from nearmisses显示文摘	Cvitkovic E	1998	Sem in Oncol1998，25，2：	1
9	C-erbB-2 in breast cancer:development of a clinically useful marker显示文摘	Hayes DF Thor AD	2002	Sem In Oncol2002，29，3：	1
10	Oxalipatin for the treatment of advanced colorectal cnacer; future directions显示文摘	Pecteux M Louret C Bekradda M	1998	Sem in Oncol1998，25，2：	1
11	Clinical aspects and molecularbasis of oxaliplatin neurotoxicity:current management and development of preventive measures显示文摘	Gamelin E Gamelin L Bossi L	2002	Sem In Oncol2002，29，1：	1
12	Clinical aspects and molecular basis of oxaliplatin neurotoxicity:current management and development of preventive measures显示文摘	Gamelin E Gamelin L Bossi L	2002	Sem In Oncol2002，29，：	1
13	Pharmacokinetics and safety profile on oxaliplatin显示文摘	Extra JM Marty M Brienza S	1998	Sem in Oncol1998，25，25：	1
14	Clinical aspectsand molecularbasis of oxaliplatin neurotoxicity : current manage-ment and development of preventive measures 显示文摘	GAMELIN E GAMELIN L BOSSI L	2002	Sem In Oncol2002，29，1：	1
15	Radio immunotherapy for non- Hodgkin's lymphoma显示文摘	Emmanouilides C	2003	Sem in Oncol2003，30，4：	1
16	Emerging strategies in bone health management for the adjuvant patient显示文摘	Coleman RE	2007	Sem in Oncol2007，34，6：	1
17	Rituximab:mechanism of action and resisitance显示文摘	Smith B Rose A	2002	Sem in Oncol2002，29，2：	1
18	The role of prymary chemotherapy in early breast cancer显示文摘	Harris L Swain SM	1996	Sem in Oncol1996，23，：	1
19	Selective dose es-calation of chemoradiotherapy for esophageal cancer:role of treat-ment intensification显示文摘	Seung SK Smith JW Mo lendyk J	2004	Sem in Oncol2004，31，618：	1
20	A historical perspective on oxalipatin:rethinking the role of platinum compounds and learning from nearmisses显示文摘	Cvitkovic E	1998	Sem in Oncol1998，25，2：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示